Patent details

EP1443933 Title: Treatment of chronic myelogenous leukemia, resistant or intolerant to ST1571, involving homoharrintonine alone or combined with other agents.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1443933
WO Application Number:
IB2002003992
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP02772653.8
WO Publication Number:
WO2003020252
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Australia (AU)
Publications:

Dates

Filing date:
05/09/2002
Grant date:
09/12/2009
EP Publication Date:
09/12/2009
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/10/2018
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
09/12/2009
EP B1 Publication Date:
09/12/2009
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
04/09/2022
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
05/07/2016
 
 

 

Name:
Teva Pharamceuticals International GmbH
Address:
Schlüsselstrasse 12, 8645, JONA, Switzerland (CH)

Historical Applicant/holder

From:
05/07/2016
To:
05/07/2016

 

Name:
ChemGenex Pharmaceuticals Pty Ltd.
Address:
Level 2, 37-39 Epping Road Macquarie Park, New South Wales, Australia (AU)

From:
05/07/2016
To:
05/07/2016

 

Name:
Ivax International GmbH
Address:
Alpenstrasse 2, 8640, Rapperswill, Switzerland (CH)

From:
09/12/2009
To:
05/07/2016

 

Name:
ChemGenex Pharmaceuticals Limited
Address:
Level 4 199 Moorabool St, 3220, Geelong, Victoria, Australia (AU)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
09/12/2009
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Jean-Pierre ROBIN
Address:
F-72000, Le Mans, France (FR)

2

Name:
François-Xavier MAHON
Address:
F-33000, Bordeaux, France (FR)

3

Name:
Hervé MAISONNEUVE
Address:
F-85000, La Roche Sur Yon, France (FR)

4

Name:
Frederick,c/o Hôpital de Hautepierre MALOISEL
Address:
F-67100, Strasbourg, France (FR)

5

Name:
Julie BLANCHARD
Address:
F-72000, Le Mans, France (FR)

Priority

Priority Patent Number:
316967 P
Priority Date:
05/09/2001
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 31/55;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
19/19
Publication date:
08/05/2019
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
39/16
Publication date:
28/09/2016
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
39/16
Publication date:
28/09/2016
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
CO
Journal edition number:
39/16
Publication date:
28/09/2016
Description:
Changes in the Netherlands Patent Register

5

Bulletin Heading:
EP4
Journal edition number:
2010/04
Publication date:
01/04/2010
Description:
European patents granted in amended form for the Netherlands

6

Bulletin Heading:
EP2
Journal edition number:
2010/02
Publication date:
01/02/2010
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
200950
Publication date:
09/12/2009
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201601903B
Date Registered:
05/07/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
ChemGenex Pharmaceuticals Pty Ltd.
Address:
Level 2, 37-39 Epping Road Macquarie Park, New South Wales, Australia (AU)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201601903C
Date Registered:
05/07/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Ivax International GmbH
Address:
Alpenstrasse 2, 8640, Rapperswill, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201601903D
Date Registered:
05/07/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Teva Pharamceuticals International GmbH
Address:
Schlüsselstrasse 12, 8645, JONA, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
21/09/2017
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
1000 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
27/09/2016 Outgoing Correspondence Letter registration deed 2 PDF /3/5/6/2/7/0502772653/docs/ep02772653.8_4_86588l118.pdf
05/07/2016 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /3/5/6/2/7/0502772653/docs/ep02772653.8_1_incomingcorrespondencepaper20160831093807740.pdf
05/07/2016 Request for Change First filed deed 36 PDF /3/5/6/2/7/0502772653/docs/ep02772653.8_2_rfc20160831093807829.pdf
19/01/2010 Claims Translated claims 4 PDF /3/5/6/2/7/0502772653/docs/ep02772653.8_0_claims20100119.pdf
19/01/2010 Incoming Correspondence Paper Correspondence address details 1 PDF /3/5/6/2/7/0502772653/docs/ep02772653.8_5_incomingcorrespondencepaper20100119.pdf
30/10/2009 Incoming Correspondence Paper Other 1 PDF /3/5/6/2/7/0502772653/docs/ep02772653.8_3_incomingcorrespondencepaper20091030.pdf